Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2015

01-03-2015 | General Gynecology

The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model

Authors: Nilufer Cetinkaya, Rukset Attar, Gazi Yildirim, Cem Ficicioglu, Ferda Ozkan, Bayram Yilmaz, Narter Yesildaglar

Published in: Archives of Gynecology and Obstetrics | Issue 3/2015

Login to get access

Abstract

Aims

To determine the effects of different doses of melatonin treatment on endometrial implants, the activity of antioxidant enzyme superoxide dismutase (SOD), the angiogenesis factor, the vascular endothelial growth factor (VEGF) and the waste metabolite product of lipid peroxidation malondialdehyde (MDA) in an oophorectomized rat endometriosis model.

Methods

Thirty-two, female, non-pregnant, nulligravid Sprague–Dawley, albino rats were used in this prospective, randomized, controlled and experimental study. Endometriosis was surgically induced in oophorectomized rats, and estradiol treatment was started after the first operation and continued till the end of the study. Second look, third look and necropsy operations were performed in the 2nd, 4th and 6th weeks. Mean volumes, histological scores and biochemical parameters were evaluated throughout the study.

Results

The mean volumes of endometriotic foci were 98.8 mm3 ± 17.2 vs. 108.2 mm3 ± 17.5, 54.1 mm3 ± 15.6 vs. 25.8 mm3 ± 3.6, 42.8 mm3 ± 10.5 vs. 32.7 mm3 ± 6.0 and histopathological scores were 2.2 ± 0.2 vs. 1.7 ± 0.1, 2.6 ± 0.2 vs. 2.2 ± 0.2, 2.6 ± 0.1 vs. 2.7 ± 0.2 in the 10 vs. 20-mg/kg/day melatonin group at the end of the second, fourth and sixth weeks, respectively. When the groups were compared, no significant differences were seen in the histopathologic scores, SOD and VEGF levels between the groups. However, the endometriotic foci volumes were significantly decreased in both melatonin treatment groups with respect to the control group at the end of the fourth and sixth weeks. Moreover, the mean MDA levels were significantly lower in the control group than in the 10-mg/kg/day melatonin group at the end of the fourth and sixth weeks.

Conclusion

Melatonin treatment resulted in the regression of endometriotic lesions in oophorectomized rats. Higher doses of melatonin treatment might be more effective in the regression of implants and improvement of histologic scores as well as in the precise evaluation of SOD, MDA and VEGF distributions in the rat experimental models.
Literature
1.
go back to reference Bernardi Lia A, Pavone ME (2013) Endometriosis: an update on management. Women’s Health 9(3):233–250PubMedCrossRef Bernardi Lia A, Pavone ME (2013) Endometriosis: an update on management. Women’s Health 9(3):233–250PubMedCrossRef
2.
go back to reference Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ (2011) Novel therapies targeting endometriosis. Reprod Sci 18(9):814–823PubMedCentralPubMedCrossRef Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ (2011) Novel therapies targeting endometriosis. Reprod Sci 18(9):814–823PubMedCentralPubMedCrossRef
3.
go back to reference Nap AW, Groothuis PG et al (2004) Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 18(2):233–244PubMedCrossRef Nap AW, Groothuis PG et al (2004) Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 18(2):233–244PubMedCrossRef
4.
go back to reference Seli E, Arici A (2003) Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med 21(2):135–144PubMedCrossRef Seli E, Arici A (2003) Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med 21(2):135–144PubMedCrossRef
5.
go back to reference Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T (2010) Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep 37(1):369–374PubMedCrossRef Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T (2010) Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep 37(1):369–374PubMedCrossRef
6.
go back to reference Zhang X, Hei P, Deng L, Lin J (2007) Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13(2):135–140PubMedCrossRef Zhang X, Hei P, Deng L, Lin J (2007) Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13(2):135–140PubMedCrossRef
7.
go back to reference Iwabe T, Harada T, Terakawa N (2002) Role of cytokines in endometriosis-associated infertility. Gynecol Obstet Invest 53:19–25PubMedCrossRef Iwabe T, Harada T, Terakawa N (2002) Role of cytokines in endometriosis-associated infertility. Gynecol Obstet Invest 53:19–25PubMedCrossRef
8.
9.
go back to reference Gupta S, Agarwal A, Krajcir N, Alvarez JG (2006) Role of oxidative stress in endometriosis. Reprod Biomed Online 13:126–134PubMedCrossRef Gupta S, Agarwal A, Krajcir N, Alvarez JG (2006) Role of oxidative stress in endometriosis. Reprod Biomed Online 13:126–134PubMedCrossRef
10.
go back to reference Carvalho LF, Abrão MS, Biscotti C, Sharma R, Nutter B, Falcone T (2013) Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci. 20(6):688–698PubMedCrossRef Carvalho LF, Abrão MS, Biscotti C, Sharma R, Nutter B, Falcone T (2013) Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci. 20(6):688–698PubMedCrossRef
11.
go back to reference Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M (2003) Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79:1288–1293PubMedCrossRef Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M (2003) Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79:1288–1293PubMedCrossRef
12.
go back to reference Polak G, Koziol-Montewka M, Gogacz M, Tarkowski R, Kotarski J (2001) Total antioxidant status of peritoneal fluid in infertile women. Europ J Obstet Gynecol Reprod Biol 94:261–263CrossRef Polak G, Koziol-Montewka M, Gogacz M, Tarkowski R, Kotarski J (2001) Total antioxidant status of peritoneal fluid in infertile women. Europ J Obstet Gynecol Reprod Biol 94:261–263CrossRef
13.
go back to reference Arendt J (1995) Melatonin and the mammalian pineal gland. Chapman & Hall, London Arendt J (1995) Melatonin and the mammalian pineal gland. Chapman & Hall, London
14.
go back to reference Pevet P, Bothorel B, Slotten H, Saboureau M (2002) The chronobiotic properties of melatonin. Cell Tissue Res 309:183–191PubMedCrossRef Pevet P, Bothorel B, Slotten H, Saboureau M (2002) The chronobiotic properties of melatonin. Cell Tissue Res 309:183–191PubMedCrossRef
15.
go back to reference Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA (2006) Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 1757(5–6):573–589PubMedCrossRef Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA (2006) Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 1757(5–6):573–589PubMedCrossRef
16.
go back to reference Karbownik M, Garcia JJ, Lewinski A, Reiter RJ (2001) Carcinogeninduced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr 33:73–78PubMedCrossRef Karbownik M, Garcia JJ, Lewinski A, Reiter RJ (2001) Carcinogeninduced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr 33:73–78PubMedCrossRef
17.
go back to reference Reiter RJ, Tan DX, Manchester LC, Qi W (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 34:237–256PubMedCrossRef Reiter RJ, Tan DX, Manchester LC, Qi W (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 34:237–256PubMedCrossRef
18.
go back to reference Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ (2001) Increased level of oxidatively damaged DNA induced by chromium (III) and H2O2: protection by melatonin and related molecules. J Pineal Res 29:54–61CrossRef Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ (2001) Increased level of oxidatively damaged DNA induced by chromium (III) and H2O2: protection by melatonin and related molecules. J Pineal Res 29:54–61CrossRef
19.
go back to reference Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181–197PubMedCrossRef Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181–197PubMedCrossRef
20.
go back to reference Guerrero JM, Reiter RJ (2002) Melatonin–immune system relationships. Curr Top Med Chem 2:167–179PubMedCrossRef Guerrero JM, Reiter RJ (2002) Melatonin–immune system relationships. Curr Top Med Chem 2:167–179PubMedCrossRef
21.
go back to reference Esquifino AI, Pandi-Perumal SR, Cardinali DP (2004) Circadian organization of the immune response: a role for melatonin. Clin Appl Immunol Rev 4:423–433CrossRef Esquifino AI, Pandi-Perumal SR, Cardinali DP (2004) Circadian organization of the immune response: a role for melatonin. Clin Appl Immunol Rev 4:423–433CrossRef
22.
go back to reference Maestroni GJM, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13:19–30PubMedCrossRef Maestroni GJM, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13:19–30PubMedCrossRef
23.
go back to reference Maestroni GJM (1998) Is hematopoiesis under the influence of neural and neuroendocrine mechanisms? Histol Histopathol 13:271–274PubMed Maestroni GJM (1998) Is hematopoiesis under the influence of neural and neuroendocrine mechanisms? Histol Histopathol 13:271–274PubMed
24.
go back to reference Tamura H, Nakamura Y, Korkmaz A et al (2009) Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 92(1):328–343PubMedCrossRef Tamura H, Nakamura Y, Korkmaz A et al (2009) Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 92(1):328–343PubMedCrossRef
25.
go back to reference García-Pergañeda A, Pozo D, Guerrero JM, Calvo JR (1997) Signal transduction for melatonin in human lymphocytes: Involvement of a pertussistoxin sensitive G protein. J Immunol 159:3774–3781PubMed García-Pergañeda A, Pozo D, Guerrero JM, Calvo JR (1997) Signal transduction for melatonin in human lymphocytes: Involvement of a pertussistoxin sensitive G protein. J Immunol 159:3774–3781PubMed
26.
go back to reference Barjavel MJ, Mamdouh Z, Raghbate N, Bakouche O (1998) Differential expression of the melatonin receptor in human monocytes. J Immunol 160:1191–1197PubMed Barjavel MJ, Mamdouh Z, Raghbate N, Bakouche O (1998) Differential expression of the melatonin receptor in human monocytes. J Immunol 160:1191–1197PubMed
27.
28.
go back to reference Petrovsky N, Harrison L (1998) The chronobiology of human cytokine production. Int Rev Immunol 16:635–649PubMedCrossRef Petrovsky N, Harrison L (1998) The chronobiology of human cytokine production. Int Rev Immunol 16:635–649PubMedCrossRef
29.
go back to reference Raghavendra V, Singh V, Kulkarni SK, Agrewala JN (2001) Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 221:57–62PubMedCrossRef Raghavendra V, Singh V, Kulkarni SK, Agrewala JN (2001) Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 221:57–62PubMedCrossRef
30.
go back to reference Kang JC, Ahn M, Kim YS, Moon C, Lee Y, Wie MB et al (2001) Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci 2:85–89PubMed Kang JC, Ahn M, Kim YS, Moon C, Lee Y, Wie MB et al (2001) Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci 2:85–89PubMed
31.
go back to reference Voznesenskaya T, Makogon N, Bryzgina T, Sukhina V, Grushka N, Alexeyeva I (2007) Melatonin protects against experimental immune ovarian failure in mice. Reprod Biol 7:207–220PubMed Voznesenskaya T, Makogon N, Bryzgina T, Sukhina V, Grushka N, Alexeyeva I (2007) Melatonin protects against experimental immune ovarian failure in mice. Reprod Biol 7:207–220PubMed
32.
go back to reference Guney M, Oral B, Karahan N, Mungan T (2008) Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 89:934–942PubMedCrossRef Guney M, Oral B, Karahan N, Mungan T (2008) Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 89:934–942PubMedCrossRef
33.
go back to reference Yildirim G, Attar R, Ozkan F, Kumbak B, Ficicioglu C, Yesildaglar N (2010) The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study. Fertil Steril 93:1787–1792PubMedCrossRef Yildirim G, Attar R, Ozkan F, Kumbak B, Ficicioglu C, Yesildaglar N (2010) The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study. Fertil Steril 93:1787–1792PubMedCrossRef
34.
go back to reference Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudleb MR, Bukovsky A (1999) Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72:135–141PubMedCrossRef Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudleb MR, Bukovsky A (1999) Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72:135–141PubMedCrossRef
35.
go back to reference Kocadal NC, Attar R, Yıldırım G, Fıçıcıoğlu C, Özkan F, Yılmaz B, Yesildaglar N (2013) Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. JTGGA 14(2):81–86 Kocadal NC, Attar R, Yıldırım G, Fıçıcıoğlu C, Özkan F, Yılmaz B, Yesildaglar N (2013) Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. JTGGA 14(2):81–86
36.
go back to reference Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C (2013) An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 14(3):291–305 (Review)PubMedCrossRef Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C (2013) An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 14(3):291–305 (Review)PubMedCrossRef
37.
go back to reference Hughes E, Fedorkow D, Collins J, Vandekerckhove P (2003) Ovulation suppressionfor endometriosis. Cochrane Database Syst Rev 3:CD000155PubMed Hughes E, Fedorkow D, Collins J, Vandekerckhove P (2003) Ovulation suppressionfor endometriosis. Cochrane Database Syst Rev 3:CD000155PubMed
38.
39.
go back to reference Schwertner A, Conceicao Dos Santos CC, Costa GD, Deitos A, de Souza A, de Souza IC et al (2013) Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. Pain 154(6):874–881PubMedCrossRef Schwertner A, Conceicao Dos Santos CC, Costa GD, Deitos A, de Souza A, de Souza IC et al (2013) Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. Pain 154(6):874–881PubMedCrossRef
40.
go back to reference Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Swarnakar S (2008) Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44:439–449PubMedCrossRef Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Swarnakar S (2008) Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44:439–449PubMedCrossRef
Metadata
Title
The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model
Authors
Nilufer Cetinkaya
Rukset Attar
Gazi Yildirim
Cem Ficicioglu
Ferda Ozkan
Bayram Yilmaz
Narter Yesildaglar
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2015
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3466-3

Other articles of this Issue 3/2015

Archives of Gynecology and Obstetrics 3/2015 Go to the issue